Advertisement

Author: Michael Kudrna

Dominance in the HIV Market

Gilead Science (GILD) seemed to be on a roll lately, but has been met with a downgrade by the firm Morgan Joseph due to upcoming patent expiration concerns this decade.  At the time of writing this, GILD was trading off its...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.